No evidence of increased anti‐M3 muscarinic acetylcholine receptor autoantibodies in SSA‐positive connective tissue disease patients

Validation of an indirect ELISA assay for assessment of autoantibodies against full-length TRIM21 and its individual domains

(2023) Marie Louise Næstholt Dahl et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib

(2021) Yu-Lan Chen et al.   Frontiers in Immunology

Autoantibodies against muscarinic acetylcholine receptor M sub 3 sub in Sjogren rsquo s syndrome and corresponding mouse models

(2018) Xinhua Yu   Frontiers in Bioscience-Landmark

Common and Specific Associations of Anti-SSA/Ro60 and Anti-Ro52/TRIM21 Antibodies in Systemic Lupus Erythematosus

(2013) Aurora Menéndez et al.   TheScientificWorldJOURNAL

Clinical and Pathological Roles of Ro/SSA Autoantibody System

(2012) Ryusuke Yoshimi et al.   Clinical & Developmental Immunology

Diagnostic significance of measuring antibodies to cyclic type 3 muscarinic acetylcholine receptor peptides in primary Sjogren's syndrome

(2011) J. He et al.   RHEUMATOLOGY

New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome

(2010) H. Tsuboi et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients

(2008) N.-Y. Koo et al.   RHEUMATOLOGY